VMD Earnings Results and History
Viemed Healthcare, Inc.'s earnings at a glance: the latest results and outlook from the press release, revenue, margins and EPS for every quarter from the company's SEC filings, and how the stock moved after each report. New results show here within about a minute of being filed.
- EPS$0.11 vs $0.12 est −10.8%
- Revenue$80.7M vs $80.8M est −0.1%
- OutlookFY2026: $316M to $320M revenue
Filed ยท Press release
Key takeaways
AI summary of the press release- Record quarterly revenue of $80.7M, up 12.2% year over year and 3.3% sequentially.
- GAAP diluted EPS of $0.11 versus $0.09 a year ago. Net income attributable to Viemed rose 32% to $4.6M.
Filings and dates
SEC EDGAR- Nov 4, 2026Earnings release, Q3 20268-K Press release
Also see VMD institutional ownership and the earnings calendar.
VMD earnings FAQ
What were VMD's latest earnings?
For Q3 2026 Viemed Healthcare, Inc. reported revenue of $80.7M, GAAP EPS of $0.11. The results were filed with the SEC on Nov 4, 2026.
When is VMD's next earnings date?
There is no confirmed date on our calendar yet. Most companies report about four to six weeks after each quarter ends.
Where do these numbers come from?
Results, guidance and financials come from Viemed Healthcare, Inc.'s own SEC filings: the earnings press release (Form 8-K) and the quarterly and annual reports (10-Q and 10-K). Key takeaways are an AI summary of the press release. Estimates and price moves come from market data.
For informational and educational purposes only. Not investment advice, and not a recommendation to buy or sell any security. Results come from company filings with the SEC. Estimates are consensus figures from before each report. Key takeaways are an AI summary of the company's press release and may contain errors; the press release is the authoritative source.